GlassScriptPhysician profile
Sangtae Park
NPI 1356300487
$3,615.02
in general payments reported to CMS, 2019-2025
14 companies · $606 in 2025
The $606 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $127 · 2021: $143 · 2022: $1,263 · 2023: $246 · 2024: $762 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064 · Travel and Lodging: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.14 |
| Travel and Lodging | $549.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,714.43 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Intuitive Surgical, INC. | $881.23 | 2023-2025 | Da Vinci Surgical System |
| Calyxo, INC. | $297.91 | 2025 | Cvac Aspiration System |
| Olympus America INC. | $171.65 | 2022-2023 | Olympus |
| Procept Biorobotics Corporation | $114.25 | 2025 | |
| Travere Therapeutics, INC. | $101.10 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $86.74 | 2020 | |
| Healthtronics Stone Solutions, LLC | $67.97 | 2022 | |
| Conmed Corporation | $55.56 | 2023 | Airseal |
| Urogen Pharma, INC. | $36.06 | 2023 | |
| Photocure INC | $30.05 | 2019 | |
| Ethicon US, LLC | $25.00 | 2023 | Echelon; Endopath |
| Neotract INC. | $16.84 | 2020 | |
| 180 Medical, INC. | $16.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sangtae Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.